~ Osteoporosis: How Calcium Combines With Other Nutrients to Combat Bone Loss - References


1. Available at: http://www.nof.org/advocacy/ prevalence. Accessed August 21, 2004.

2. Beers MH, Berkow R, eds. The Merck Manual, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999:469-73.

3. Available at:.http://www.nof.org. Accessed August 21, 2004.

4. Seeman E. Osteoporosis in men. Baillieres Clin Rheumatol. 1997 Aug;11(3):613-29.

5. Baldock PA, Eisman JA. Genetic determinants of bone mass. Curr Opin Rheumatol. 2004 Jul;16(4):450-6.

6. Available at: http://www.gsdl.com. Accessed August 22, 2004.

7. Sandyk R, Anastasiadis PG, Anninos PA, Tsagas N. Is postmenopausal osteoporosis related to pineal gland functions? Int J Neurosci. 1992 Feb;62(3-4):215-25.

8. Elliott ME, Binkley N. Evaluation and mea- surement of bone mass. Epilepsy Behav. 2004 Feb;5 Suppl 2:S16-S23.

9. Available at: http://www.nof.org/physguide/diagnosis.htm. Accessed August 27, 2004.

10. Whiting SJ, Lemke B. Excess retinol intake may explain the high incidence of osteo- porosis in northern Europe. Nutr Rev. June 1999;57:192-5.

11. Drevon CA, Henriksen HB, Sanderud M, Gundersen TE, Blomhoff R. Biological effects of vitamin K and concentration of vitamin K in Norwegian food. Tidsskr Nor Laegeforen. 2004 Jun 17;124(12):1650-4.

12. Available at: http://www.nof.org/prevention/calcium.htm. Accessed August 26, 2004.

13. Lloyd T, Andon MB, Rollings N, et al. Calcium supplementation and bone mineral density in adolescent girls. JAMA. 1993 Aug 18;270(7):841-4.

14. Lloyd T, Martel JK, Rollings N, et al. The effect of calcium supplementation and Tanner stage on bone density, content and area in teenage women. Osteoporos Int. 1996;6(4):276-83.

15. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium sup- plementation on bone density in postmenopausal women. N Engl J Med. 1990 Sep 27;323(13):878-83.

16. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997 Sep 4;337(10):670-6.

17. Available at: www.aeron.com. Accessed August 26, 2004.

18. Kirk D, Fish SA. Medical management of osteoporosis. Am J Manag Care. 2004 Jul;10(7 Pt 1):445-55.

19. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003 Oct;88(10):4740-7.

20. Laszlo A. Postmenopausal osteoporosis. Orv Hetil. 2004 Jan;145(1):3-13.

21. Staren ED, Omer S. Hormone replacement therapy in postmenopausal women. Am J Surg. 2004 Aug;188(2):136-49.

22. Leifke E, Korner HC, Link TM, Berhre HM, Peters PE, Nieschlag E. Effects of testosterone replacement therapy on corti- cal and trabecular bone mineral density, vertebral body area, and paraspinal muscle area in hypogonadal men. Eur J Endocrinol. 1998 Jan;138(1):51-8.

23. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiolís effects on postmenopausal bone density and sexu- ality. Maturitas. 1995 Apr;21(3):227-36.

24. Lee JR. Is natural progesterone the missing link in osteoporosis prevention and treatment? Med Hypotheses. 1991 Aug;35(4):316-8.

25. Whitfield JF, Morley P. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis. Trends Pharmacol Sci. 1995 Nov;16(11):382-6.

26. Frolik CA, Black EC, Cain RL, et al. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone. 2003 Sep;33(3):372-9.

27. Quattrocchi E, Kourlas H. Teriparatide: a review. Clin Ther. 2004 Jun;26(6):841-54.

28. Lane NE. Parathyroid hormone: evolving therapeutic concepts. Curr Opin Rheumatol. 2004 Jul;16(4):457-63.

29. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporot- ic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvita- min D. J Bone Miner Res. 1986 Aug;1(4):377-81.

30. Doggrell SA. Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis? Expert Opin Pharmacother. 2004 Apr;5(4):955-8.

31. Available at: http://www.nof.org/physguide/ univeral_recommendations.htm#adequate. Accessed August 27, 2004.

32. PDR, 58th ed. Montvale, NJ: Thomson PDR; 2004:1989, 2827-8.

33. Smith KT, Heaney RP, Flora L, Hinders SM. Calcium absorption from a new calcium delivery system (CCM). Calcif Tissue Int. 1987 Dec;41(6):351-2.

34. Cited in: PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:75.

35. Kenny AM, Prestwood KM, Biskup B, et al. Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporos Int. 2004 Apr;15(4):290- 4.

36. Ishitani K, Itakura E, Goto S, Esashi T. Calcium absorption from the ingestion of coral-derived calcium by humans. J Nutr Sci Vitaminol (Tokyo). 1999 Oct;45(5):509-17.

37. Wallace K, Baron JA, Cole BF, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16;96(12):921-5.

38. Tucker KL. Dietary intake and bone status with aging. Curr Pharm Des. 2003;9(32):2687-704.

39. Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in post- menopausal women supplemented with calcium and trace minerals. J Nutr. 1994 Jul;124(7):1060-4.

40. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:288-95.

41. Reffitt DM, Ogston N, Jugdaohsingh R, et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003 Feb;32(2):127-35.

42. Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res. 1993 Sep;6(3):247-9.

43. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:60-3.

44. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S-45S.

45. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842-56.

46. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care. 2000 Nov;3(6):433-8.

47. Stone I. Scurvy, the cosmic connection: an ancient supernova and the practice of medicine in the twentieth century. In: Huemer RP, ed. The Roots of Molecular Medicine: A Tribute to Linus Pauling. New York: W. H. Freeman; 1986:48-56.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.